# MINT

The Menthol In Neuropathy Trial (MINT) is a phase II randomised clinical trial investigating the potential of 3% topical levomenthol gel compared to placebo in relieving symptoms of chemotherapy-induced peripheral neuropathy (CIPN). 

Initial analyses of the main study outcomes (primary outcome + majority of secondary study outcomes) were performed independently by the Edinburgh Clinical Trials Unit. 
Presented here is code for data cleaning, analysis replication (R) and extensions of the analyses, including the analyses of the (f)MRI data. 

For more details on the study, please see our OSF page https://osf.io/3a6fp/
ClinicalTrials.gov Identifier: NCT04276727
